Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
- Author(s)
- Klein, O; Kee, D; Nagrial, A; Markman, B; Underhill, C; Michael, M; Behren, A; Palmer, J; Tebbutt, NC; Carlino, MS; Cebon, J;
- Details
- Publication Year 2023-04-01,Volume 129,Issue #7,Page 1129-1130
- Journal Title
- Cancer
- Publication Type
- Correspondence
- Publisher
- Wiley
- Keywords
- Humans; CTLA-4 Antigen; Antibodies, Monoclonal/therapeutic use; *Melanoma; *Bile Duct Neoplasms; Immunotherapy
- Department(s)
- Medical Oncology
- PubMed ID
- 36692958
- Publisher's Version
- https://doi.org/10.1002/cncr.34660
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-05-30 07:27:54
Last Modified: 2023-05-30 07:28:52